VasoRX — Operating Costs
Verified$280K
Funder
Recipient
VasoRX
Date
Oct 2024
Data source
Source
Notes
[Scientific Research] Open Philanthropy recommended an investment of $280,000 in VasoRX, a company that has discovered and patented a novel lipid nanoparticle capable of delivering RNA interference medication specifically to the vascular endothelium without targeting other tissues such as liver. The company has also discovered that the technology can be used in combination with a specific RNA to reverse pulmonary hypertension and atherosclerosis in preclinical models. This falls within our focus area of scientific research.
Other Grants by Coefficient Giving
2625| Grant | Recipient | Amount | Date |
|---|---|---|---|
| Janaagraha — Air Quality Grants Assessment | $195K | Dec 2024 | |
| Futurewise — Housing Advocacy in Washington | $450K | Apr 2023 | |
| Exscientia — Agonists for Interferon Lambda | $2.3M | Sep 2023 | |
| Kurzgesagt — Short-form Video Content | $3M | Mar 2022 | |
| Kurzgesagt — Video Production (2023) | $1.7M | May 2023 | |
| Kurzgesagt — Video Creation and Translation | $2.6M | Dec 2021 | |
| Lightcone Infrastructure – General Support | Lighthaven (Event Venue) | $4.5M | Sep 2022 |
| Lightcone Infrastructure — General Support (2023) | Lighthaven (Event Venue) | $3M | Oct 2023 |
| Conjecture — Cybersecurity Bootcamp | Conjecture | $223K | Jun 2025 |
| Conjecture — AI Safety Technical Program | Conjecture | $224K | May 2023 |
Showing 10 of 2625 grants